vs
DIGI INTERNATIONAL INC（DGII）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是DIGI INTERNATIONAL INC的1.0倍（$127.1M vs $122.5M），DIGI INTERNATIONAL INC同比增速更快（17.9% vs 17.1%），DIGI INTERNATIONAL INC自由现金流更多（$35.2M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 6.6%）
Digi International Inc.是总部位于美国明尼苏达州霍普金斯的工业物联网（IIoT）科技企业，成立于1985年。上世纪90年代初，该公司以生产多线路串行数据卡闻名，可支持兼容机运行多线路公告板系统（BBS）。90年代末互联网兴起后，公司逐步转向网络接入设备与工业监测领域布局。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
DGII vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.0倍
$122.5M
营收增速更快
DGII
高出0.8%
17.1%
自由现金流更多
DGII
多$61.9M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
6.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $122.5M | $127.1M |
| 净利润 | $11.7M | — |
| 毛利率 | 62.4% | 51.0% |
| 营业利润率 | 13.3% | -54.6% |
| 净利率 | 9.6% | — |
| 营收同比 | 17.9% | 17.1% |
| 净利润同比 | 16.1% | — |
| 每股收益（稀释后） | $0.31 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DGIIZLAB
| Q4 25 | $122.5M | $127.1M | ||
| Q3 25 | $114.3M | $115.4M | ||
| Q2 25 | $107.5M | $109.1M | ||
| Q1 25 | $104.5M | $105.7M | ||
| Q4 24 | $103.9M | $108.5M | ||
| Q3 24 | $105.1M | $101.8M | ||
| Q2 24 | $105.2M | $100.1M | ||
| Q1 24 | $107.7M | $87.1M |
净利润DGIIZLAB
| Q4 25 | $11.7M | — | ||
| Q3 25 | $10.0M | $-36.0M | ||
| Q2 25 | $10.2M | $-40.7M | ||
| Q1 25 | $10.5M | $-48.4M | ||
| Q4 24 | $10.1M | — | ||
| Q3 24 | $11.9M | $-41.7M | ||
| Q2 24 | $9.7M | $-80.3M | ||
| Q1 24 | $4.0M | $-53.5M |
毛利率DGIIZLAB
| Q4 25 | 62.4% | 51.0% | ||
| Q3 25 | 63.9% | 59.5% | ||
| Q2 25 | 63.5% | 60.6% | ||
| Q1 25 | 62.1% | 63.6% | ||
| Q4 24 | 62.0% | 61.5% | ||
| Q3 24 | 61.1% | 64.1% | ||
| Q2 24 | 59.2% | 64.9% | ||
| Q1 24 | 57.9% | 61.4% |
营业利润率DGIIZLAB
| Q4 25 | 13.3% | -54.6% | ||
| Q3 25 | 12.5% | -42.3% | ||
| Q2 25 | 13.9% | -50.3% | ||
| Q1 25 | 13.1% | -53.3% | ||
| Q4 24 | 12.9% | -62.6% | ||
| Q3 24 | 14.2% | -66.6% | ||
| Q2 24 | 12.3% | -76.0% | ||
| Q1 24 | 7.6% | -80.7% |
净利率DGIIZLAB
| Q4 25 | 9.6% | — | ||
| Q3 25 | 8.7% | -31.2% | ||
| Q2 25 | 9.5% | -37.3% | ||
| Q1 25 | 10.0% | -45.8% | ||
| Q4 24 | 9.7% | — | ||
| Q3 24 | 11.3% | -40.9% | ||
| Q2 24 | 9.2% | -80.2% | ||
| Q1 24 | 3.7% | -61.4% |
每股收益（稀释后）DGIIZLAB
| Q4 25 | $0.31 | $-0.05 | ||
| Q3 25 | $0.26 | $-0.03 | ||
| Q2 25 | $0.27 | $-0.04 | ||
| Q1 25 | $0.28 | $-0.04 | ||
| Q4 24 | $0.27 | $-0.09 | ||
| Q3 24 | $0.32 | $-0.04 | ||
| Q2 24 | $0.26 | $-0.08 | ||
| Q1 24 | $0.11 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.9M | $689.6M |
| 总债务越低越好 | $135.0M | — |
| 股东权益账面价值 | $649.2M | $715.5M |
| 总资产 | $918.4M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.21× | — |
8季度趋势，按日历期对齐
现金及短期投资DGIIZLAB
| Q4 25 | $30.9M | $689.6M | ||
| Q3 25 | $21.9M | $717.2M | ||
| Q2 25 | $20.1M | $732.2M | ||
| Q1 25 | $26.3M | $757.3M | ||
| Q4 24 | $25.9M | $779.7M | ||
| Q3 24 | $27.5M | $616.1M | ||
| Q2 24 | $28.3M | $630.0M | ||
| Q1 24 | $23.8M | $650.8M |
总债务DGIIZLAB
| Q4 25 | $135.0M | — | ||
| Q3 25 | $159.2M | — | ||
| Q2 25 | $40.1M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | $95.0M | — | ||
| Q3 24 | $123.2M | — | ||
| Q2 24 | $151.6M | — | ||
| Q1 24 | $171.8M | — |
股东权益DGIIZLAB
| Q4 25 | $649.2M | $715.5M | ||
| Q3 25 | $636.1M | $759.9M | ||
| Q2 25 | $621.5M | $791.7M | ||
| Q1 25 | $605.2M | $810.8M | ||
| Q4 24 | $590.7M | $840.9M | ||
| Q3 24 | $581.0M | $667.7M | ||
| Q2 24 | $563.1M | $704.2M | ||
| Q1 24 | $549.6M | $762.2M |
总资产DGIIZLAB
| Q4 25 | $918.4M | $1.2B | ||
| Q3 25 | $922.6M | $1.2B | ||
| Q2 25 | $770.3M | $1.2B | ||
| Q1 25 | $781.0M | $1.2B | ||
| Q4 24 | $796.1M | $1.2B | ||
| Q3 24 | $815.1M | $985.3M | ||
| Q2 24 | $820.4M | $987.4M | ||
| Q1 24 | $825.3M | $988.4M |
负债/权益比DGIIZLAB
| Q4 25 | 0.21× | — | ||
| Q3 25 | 0.25× | — | ||
| Q2 25 | 0.06× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.27× | — | ||
| Q1 24 | 0.31× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $35.2M | $-26.7M |
| 自由现金流率自由现金流/营收 | 28.7% | -21.0% |
| 资本支出强度资本支出/营收 | 0.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 3.04× | — |
| 过去12个月自由现金流最近4个季度 | $111.4M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流DGIIZLAB
| Q4 25 | $35.6M | $-26.0M | ||
| Q3 25 | $28.0M | $-32.0M | ||
| Q2 25 | $24.0M | $-31.0M | ||
| Q1 25 | $26.3M | $-61.7M | ||
| Q4 24 | $29.7M | $-55.8M | ||
| Q3 24 | $26.4M | $-26.8M | ||
| Q2 24 | $24.9M | $-42.2M | ||
| Q1 24 | $13.1M | $-90.1M |
自由现金流DGIIZLAB
| Q4 25 | $35.2M | $-26.7M | ||
| Q3 25 | $27.5M | $-35.0M | ||
| Q2 25 | $22.9M | $-33.9M | ||
| Q1 25 | $25.7M | $-63.2M | ||
| Q4 24 | $29.1M | $-58.4M | ||
| Q3 24 | $25.5M | $-28.2M | ||
| Q2 24 | $24.5M | $-42.9M | ||
| Q1 24 | $12.5M | $-91.1M |
自由现金流率DGIIZLAB
| Q4 25 | 28.7% | -21.0% | ||
| Q3 25 | 24.1% | -30.4% | ||
| Q2 25 | 21.3% | -31.1% | ||
| Q1 25 | 24.6% | -59.9% | ||
| Q4 24 | 28.1% | -53.8% | ||
| Q3 24 | 24.3% | -27.7% | ||
| Q2 24 | 23.2% | -42.9% | ||
| Q1 24 | 11.6% | -104.5% |
资本支出强度DGIIZLAB
| Q4 25 | 0.4% | 0.5% | ||
| Q3 25 | 0.4% | 2.6% | ||
| Q2 25 | 0.9% | 2.6% | ||
| Q1 25 | 0.5% | 1.5% | ||
| Q4 24 | 0.6% | 2.4% | ||
| Q3 24 | 0.9% | 1.3% | ||
| Q2 24 | 0.5% | 0.7% | ||
| Q1 24 | 0.5% | 1.1% |
现金转化率DGIIZLAB
| Q4 25 | 3.04× | — | ||
| Q3 25 | 2.81× | — | ||
| Q2 25 | 2.34× | — | ||
| Q1 25 | 2.50× | — | ||
| Q4 24 | 2.95× | — | ||
| Q3 24 | 2.23× | — | ||
| Q2 24 | 2.57× | — | ||
| Q1 24 | 3.27× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DGII
| Io T Productsand Services | $86.4M | 71% |
| Io T Solutions | $36.1M | 29% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
